Clinical Trials Browser

Phase 1/2 × INDUSTRY × HER2-positive Breast Cancer × Clear all

NCT04170595 2021-03-03

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

Phase 1/2 Unknown

HER2-positive Breast Cancer